ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SGMO Sangamo Therapeutics Inc

0.5027
-0.0003 (-0.06%)
Pre Market
Last Updated: 05:44:45
Delayed by 15 minutes

Period:

Draw Mode:

Volume 102
Bid Price 0.503
Ask Price 0.5595
News -
Day High

Low
0.2911

52 Week Range

High
1.78

Day Low
Company Name Stock Ticker Symbol Market Type
Sangamo Therapeutics Inc SGMO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0003 -0.06% 0.5027 05:44:45
Open Price Low Price High Price Close Price Prev Close
0.503
Trades Volume Avg Volume 52 Week Range
1 102 - 0.2911 - 1.78
Last Trade Time Type Quantity Stock Price Currency
04:03:57 formt 102 $ 0.5027 USD

Sangamo Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
89.45M 178.91M - 176.23M -257.83M -1.44 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Sangamo Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No SGMO Message Board. Create One! See More Posts on SGMO Message Board See More Message Board Posts

Historical SGMO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.47870.570.460010.51005331,335,8560.0245.01%
1 Month0.67020.69380.460010.54674641,553,769-0.1675-24.99%
3 Months0.51951.480.460010.84890522,484,752-0.0168-3.23%
6 Months0.4741.480.29110.67291212,031,5310.02876.05%
1 Year1.611.780.29110.86287622,072,449-1.11-68.78%
3 Years11.8012.82970.29113.611,625,858-11.30-95.74%
5 Years11.8519.430.29116.551,694,283-11.35-95.76%

Sangamo Therapeutics Description

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

Your Recent History

Delayed Upgrade Clock